SHW - The Sherwin-Williams Company
EP Wealth Advisors LLC acquired a new stake in shares of The Sherwin-Williams Company (NYSE: SHW) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 7,853 shares of the specialty chemicals company's stock, valued at approximately $2,704,000. Other hedge funds and
Bank of New York Mellon Corp bought a new stake in The Sherwin-Williams Company (NYSE: SHW) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 1,588,919 shares of the specialty chemicals company's stock, valued at approximately $547,097,000. Bank of New York Mellon Corp
Allworth Financial LP bought a new stake in The Sherwin-Williams Company (NYSE: SHW) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,081 shares of the specialty chemicals company's stock, valued at approximately $1,749,000. Other large investors have also made changes to
Cannon Wealth Management Services LLC acquired a new stake in The Sherwin-Williams Company (NYSE: SHW) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 12,933 shares of the specialty chemicals company's stock, valued at approximately $4,453,000. Sherwin-Williams comprises about 2.4% of Cannon
Advisors Capital Management LLC bought a new position in shares of The Sherwin-Williams Company (NYSE: SHW) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 14,614 shares of the specialty chemicals company's stock, valued at approximately $5,032,000. Other hedge funds have
Asahi Life Asset Management CO. LTD. purchased a new stake in The Sherwin-Williams Company (NYSE: SHW) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 8,967 shares of the specialty chemicals company's stock, valued at approximately $3,088,000. Sherwin-Williams comprises about 1.7% of Asahi
Aljian Capital Management LLC purchased a new position in The Sherwin-Williams Company (NYSE: SHW) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 2,284 shares of the specialty chemicals company's stock, valued at approximately $787,000. A number of other institutional investors and hedge
On August 18, 2026, we delve into the DCF analysis for Sherwin-Williams Co (SHW), a company currently priced at $349.97. The stock has shown mixed performance,
BlackRock Inc. purchased a new stake in shares of The Sherwin-Williams Company (NYSE: SHW) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 17,716,320 shares of the specialty chemicals company's stock, valued at approximately $6,100,083,000. BlackRock Inc. owned approximately 7.30% of Sherwin-Williams at the end
Baxter Bros Inc. bought a new stake in The Sherwin-Williams Company (NYSE: SHW) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 19,352 shares of the specialty chemicals company's stock, valued at approximately $6,663,000. Other hedge funds have also made changes to their
Benjamin Edwards Inc. trimmed its holdings in shares of The Sherwin-Williams Company (NYSE: SHW) by 13.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 109,813 shares of the specialty chemicals company's stock after selling 16,582 shares during
The transaction involved the sale of 7,886 shares at $368.30 per share, representing a total liquidation value of ~$2.9 million on August 7, 2026. The disposition reduced Jorgenrud's direct equity holdings by 40% when including the shares acquired via the immediate option exercise.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
After reaching an important support level, The Sherwin-Williams Company (SHW) could be a good stock pick from a technical perspective. SHW recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wall Street analysts are reshuffling their bets heading into August, and some of the calls on Monday target names that range from a crypto giant to a coffee behemoth to a semiconductor darling. Find out which stocks just got slapped with new downgrades and which ones earned fresh upgrades.
First National Bank of Mount Dora Trust Investment Services lowered its stake in shares of The Sherwin-Williams Company (NYSE: SHW) by 85.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,513 shares of the specialty chemicals company's stock after
Sherwin-Williams maintains positive volume and share gains despite weak housing demand, supporting my hold rating. SHW's Q2 results showed 7.5% net sales growth and 9.5% adj. EPS growth, but margin risks persist due to raw material cost pressures. September's 8% price increase may not be fully realized in H2, creating timing risks for margin expansion and consensus earnings estimates.
Sherwin-Williams delivered a strong Q2 2026, with double-beat results and 7.6% year-over-year revenue growth to $6.79B. SHW raised full-year 2026 EPS guidance to $11.80–$12.20, reflecting robust pricing power and segment gains, despite integration and margin headwinds from Suvinil. My free cash flow valuation model indicates SHW trades at a 12% discount to fair value, supporting a continued Buy rating.
Sherwin-Williams NYSE: SHW reported high-single-digit consolidated sales growth in the second quarter of 2026, supported by new account wins, share gains and contributions from the Suvinil acquisition, while management said broad demand conditions remained largely unchanged.